KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsR&D In ProcessShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Pfizer (PFE) Shares Repurchased (2016 - 2022)

Historic Shares Repurchased for Pfizer (PFE) over the last 11 years, with Q4 2022 value amounting to $2.0 billion.

  • Pfizer's Shares Repurchased changed N/A to $2.0 billion in Q4 2022 from the same period last year, while for Oct 2023 it was $2.0 billion, marking a year-over-year decrease of 5000.0%. This contributed to the annual value of $2.0 billion for FY2022, which is N/A changed from last year.
  • Latest data reveals that Pfizer reported Shares Repurchased of $2.0 billion as of Q4 2022.
  • Over the past 5 years, Pfizer's Shares Repurchased peaked at $8.9 billion during Q1 2019, and registered a low of $1.1 billion during Q3 2018.
  • For the 3-year period, Pfizer's Shares Repurchased averaged around $4.2 billion, with its median value being $3.5 billion (2018).
  • Per our database at Business Quant, Pfizer's Shares Repurchased soared by 2126.0% in 2018 and then surged by 4621.47% in 2019.
  • Over the past 3 years, Pfizer's Shares Repurchased (Quarter) stood at $5.0 billion in 2018, then skyrocketed by 76.24% to $8.9 billion in 2019, then crashed by 77.44% to $2.0 billion in 2022.
  • Its Shares Repurchased stands at $2.0 billion for Q4 2022, versus $2.0 billion for Q2 2022 and $8.9 billion for Q1 2019.